However, in a sub-study of the RENEXC (randomized controlled trial in CKD) involving patients with stage 3–5 CKD, 12 months of strength or balance training and aerobic exercise had no effect on FGF-23 levels [40]. The gene discussed is FGF23; the disease is chronic kidney disease.